Pharmaceutical

Trump's genial private meetings with CEOs jar with public attacks

Ginger Gibson and David Shepardson, Reuters

March 8, 2017

When the bosses of some of the world's largest pharmaceutical companies headed to Washington in January to meet U.S. President Donald Trump, it had all the makings of a potentially hostile meeting.

Trump win boosts drug stocks as prospect of price curbs recedes

Reuters

November 9, 2016

Pharmaceutical stocks leapt on Wednesday as Republican Donald Trump's U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded. News that a Californian proposal aimed at reining in rising prices for prescription drugs was headed for defeat in a state ballot also buoyed the mood.

Valeant attempts to stop the bleeding

Rod Nickel

November 18, 2015

Valeant Pharmaceuticals International Inc will likely offer cash an

Merck KGaA to Acquire Sigma-Aldrich for $17 Billion in Cash

Phil Serafino, Bloomberg

September 22, 2014

Merck KGaA agreed to buy Sigma- Aldrich Corp. for $17 billion in cash to expand in chemicals used in research labs and pharmaceutical manufacturing and reduce its dependence on drug development.

Pharmaceuticals scramble for new products

Canaccord Genuity Morning Coffee

June 26, 2011